MEDSCIENCES CAPITAL
MedSciences Capital (MSC) is a venÂture capÂiÂtal provider to early- and mid-stage comÂpaÂnies develÂopÂing innoÂvÂaÂtive prodÂucts in the medÂical life sciÂences secÂtor.
MEDSCIENCES CAPITAL
Founded:
2006-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Nginx Euro PHP PHP 7
Current Employees Featured
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2014-04-29 | Mucosis | MedSciences Capital investment in Venture Round - Mucosis | 6.9 M USD |
2012-01-25 | Prosensa | MedSciences Capital investment in Venture Round - Prosensa | 23 M EUR |
2011-01-01 | Net Medical | MedSciences Capital investment in Seed Round - Net Medical | N/A |
2010-05-19 | Pronota | MedSciences Capital investment in Series B - Pronota | 1.5 M EUR |
2010-02-23 | Organ Assist | MedSciences Capital investment in Venture Round - Organ Assist | 1.7 M EUR |
2007-09-10 | Mucosis | MedSciences Capital investment in Series A - Mucosis | 3 M EUR |
2007-06-26 | Kiadis Pharma | MedSciences Capital investment in Venture Round - Kiadis Pharma | 15 M EUR |
More informations about "MedSciences Capital" on Search Engine
MedSciences Capital - Crunchbase Investor Profile & Investments
Investor Type Venture Capital. Number of Exits. 3. Company Type For Profit. Contact Email [email protected]. MedSciences Capital (MSC) is a venture capital …See details»
MedSciences Capital Investor Profile: Portfolio & Exits | PitchBook
Description. Founded in 2000, MedSciences Capital is a venture capital investment firm based in Hague, Netherlands. The firm seeks early-stage and later-stage investments. …See details»
MedSciences Capital - Investments, Portfolio & Company Exits
Apr 29, 2014 About. MedSciences Capital has made 7 investments. Their most recent investment was on Apr 29, 2014, when Mucosis raised. $6.9M. MedSciences Capital …See details»
MedSciences Capital III: Fund Profile, Investments & Returns
Description. MedSciences Capital III will be an early-stage venture capital fund and will be managed by MedSciences Capital. The fund will be located in Hague, Netherlands. The …See details»
MedSciences Capital - Contacts, Employees, Board Members, …
MedSciences Capital (MSC) is a venture capital provider to early- and mid-stage companies developing innovative products in the.See details»
MedSciences Capital Management - CB Insights
May 31, 2001 MedSciences Capital (MSC) is a venture capital provider to early- and mid-stage companies developing products in the medical life sciences sector. …See details»
MedSciences Capital - Investor, Netherlands - SWFI
MedSciences Capital: Investor in Netherlands, Europe. MedSciences Capital is a Investor located in Netherlands, Europe. Request Profile Update; Download DataSee details»
MedSciences Capital | F6S
MedSciences Capital . We invest in therapeutics, diagnostics and medical technology products. Accelerators & Events . Startup Programs; Accelerators; Investment Funds; …See details»
Press Release: Kiadis Pharma Raises Euro 15 Million to Advance …
Jun 26, 2007 For more information about the LSP Group, please visit the website at www.lspvc.com About MedSciences Capital MedSciences Capital …See details»
MedSciences Seed Fund: Profile, Investments & Returns
Description. MedSciences Seed Fund is an early stage venture capital fund managed by MedSciences Capital. The fund is located in Hague, Netherlands. The fund targets …See details»
MedSciences Capital - Tech Stack, Apps, Patents & Trademarks
Active Tech Count 15. Monthly Visits 1,424. Monthly Visits Growth -0.21% About. MedSciences Capital uses 6 technology products and services including HTML5 , …See details»
MedSciences Capital Management BV - Company Profile and News
MedSciences Capital Management B.V. operates as a venture capital firm. The Company invests in medical life sciences companies with a focus on drug development, …See details»
MedSciences Capital — 7 Investments, Performance analytics, …
MedSciences Capital is the famous VC, which was founded in 2006. The venture was found in Europe in The Netherlands. The leading representative office of defined VC is …See details»
"Medsciences Capital" Investment News - SWFI - Sovereign …
View breaking sovereign wealth fund and investment news. Over 2,000 financial and investment articles to read with new content added every day.See details»
SEC.gov
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:See details»
Prosensa’s Hans Schikan Appointed to the Biotechnology …
San Diego, CA, June 23, 2014 (GLOBE NEWSWIRE) — Prosensa Holding N.V. (NASDAQ: RNA) the Dutch biopharmaceutical company focusing on rare diseases with a high …See details»
MedSciences Capital II Participatie B.V. - Dun & Bradstreet
Overview. Company Description: Industry: Securities and Commodity Contracts Intermediation and Brokerage , Securities, Commodity Contracts, and Other Financial …See details»
Echelon Wealth Partners faces action by Canada’s industry …
13 hours ago More recently, last November, Echelon placed a $30-million lien on the assets of hedge fund manager Traynor Ridge Capital Inc., and its deceased owner, …See details»
Net Medical - Funding, Financials, Valuation & Investors
Jan 1, 2011 Connect to CRM. Summary Financials People Signals & News Similar Companies. Highlights. Funding Rounds 1. Lead Investors 1. Investors 1. Funding. Net …See details»
Kiadis Pharma Appoints PCT as its Contract Manufacturing …
Kiadis Pharma Appoints PCT as its Contract Manufacturing Organization in the United States PCT will supply study medication for the US part of Kiadis Pharma’s Phase III …See details»